"A Phase II Study With a Sequential Clofarabine-cyclophosphamide Combination Schedule as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) in Adult Patients"
Phase of Trial: Phase II
Latest Information Update: 12 Oct 2017
At a glance
- Drugs Clofarabine (Primary) ; Cyclophosphamide (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- Acronyms LAL1610
- 09 Oct 2017 Status changed from active, no longer recruiting to completed.
- 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association
- 16 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.